Genetic therapies offer new hope against incurable brain diseases,

That compound, nusinersen, entered clinical trials in 2011. The results were so promising that the phase III trial in infants with SMA was terminated early: …, That compound, nusinersen, entered clinical trials in 2011. The results were so promising that the phase III trial in infants with SMA was terminated early: …, Read More

Scroll to Top